Nevada sued over 40 alleged opioid “conspirators” on Monday ― including manufacturers, distributors, pharmacies and individuals ― accusing them of creating “an unprecedented public health crisis for their own profit.”

The wide-ranging complaint, announced by Nevada Attorney General Aaron Ford (D), expands on a narrower lawsuit filed last year by his predecessor against Purdue Pharma, which produces OxyContin and other opioids. The latest complaint targets manufacturers including Teva Pharmaceuticals and Purdue Pharma, members of the Sackler family who own Purdue, distributors including Walgreens and CVS, and others.

The suit is part of a nationwide effort to hold companies accountable for their alleged responsibility for and involvement in the opioid crisis. Abuse of opioids caused over 47,000 deaths in the U.S. in 2017, six times higher than the number of such deaths in 1999. Nevada argues that defendants engaged in “false, deceptive and unfair marketing and/or unlawful diversion of prescription opioids,” including spreading incorrect information about addiction risk, opioid withdrawal and other forms of pain relief. The complaint also accuses distributors of negligence in their control of the substances.

“Their conspiracy to dupe doctors into prescribing more and more deadly and addictive pills has left countless Nevada families and the state suffering in the wake of their greed,” Ford said in a statement on Monday.

The lawsuit was filed in the District Court of Clark County, Nevada.

A representative for Walgreens declined to comment. CVS, Teva and the Sackler family did not immediately respond to requests for comment.

Purdue Pharma “vigorously denies the allegations” in the lawsuit, company representatives said in a statement, calling them “misleading attacks.”

“These sensationalized claims are part of a continuing effort to try these cases in the court of public opinion rather than the justice system, as plaintiffs are unable to connect the conduct alleged to the harm described,” Purdue representatives said. They cited the dismissal of North Dakota’s suit in May, when a state court there found that the complaint did not account for the actions of other actors like doctors and patients. The company also pointed to its own efforts, including implementing over 60 initiatives, to address the opioid crisis.